As for SIRPα targeting strategy, it constantly fail to induce ADCP and ADCC against cancer cells when administrated alone due to immune cells target (Chen et al., 2013; Ring et al., 2017; Labrijn et al., 2019; Chen et al., 2022). The gene discussed is SIRPA; the disease is cancer.